ARDT
Ardent Health Partners, LLC
NYSE · Healthcare · Medical - Care Facilities · US
$10.91
+1.39%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 6.4B | 6.3B | 6.0B | 5.4B | 5.1B |
| Cost of Revenue | 4.5B | 155.7M | 1.0B | 140.8M | 955.2M |
| Gross Profit | 1.9B | 6.2B | 4.9B | 5.3B | 4.2B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 1.0B | 1.2B | 3.9B | 3.6B | 3.4B |
| General & Admin Expense | 681.3M | 1.2B | 3.9B | 3.6B | 3.4B |
| Selling & Marketing Expense | 340.4M | — | — | 14.9M | — |
| Other Expenses | 414.2M | 4.7B | 642.5M | 1.4B | 585.8M |
| Total Operating Expenses | 1.4B | 5.8B | 4.5B | 5.0B | 4.0B |
| Cost and Expenses | 5.9B | 6.0B | 5.6B | 5.2B | 4.9B |
| Operating Income (EBIT) | 483.2M | 325.6M | 405.8M | 229.5M | 217.0M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 49.6M | 55.2M | 65.6M | 65.4M | 82.1M |
| Net Interest Income | (49.6M) | (55.2M) | (65.6M) | (65.4M) | (82.1M) |
| Other Non-Op Income/Expense | (275.2M) | (39.2M) | (42.7M) | (77.9M) | 94.5M |
| Non-Operating Income (excl Interest) | 246.0M | (16.0M) | (22.9M) | 20.4M | (176.5M) |
| EBT (Pre-Tax Income) | 208.0M | 286.4M | 363.1M | 151.6M | 311.5M |
| Income Tax Expense | 39.3M | 56.2M | 63.4M | 22.6M | 46.1M |
| Bottom Line | |||||
| Net Income | 78.2M | 135.8M | 210.3M | 50.3M | 188.9M |
| Earnings from Cont. Ops | 168.6M | 230.1M | 299.7M | 129.0M | 265.4M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 78.2M | 135.8M | 210.3M | 50.3M | 188.9M |
| Per Share | |||||
| Basic EPS | $0.55 | $0.96 | $1.59 | $0.35 | $1.32 |
| Diluted EPS | $0.55 | $0.96 | $1.58 | $0.35 | $1.32 |
| Revenue Per Share | $45.21 | $44.93 | $45.05 | $37.76 | $35.81 |
| Shares | |||||
| Basic Shares Outstanding | 141.7M | 140.8M | 132.4M | 143.3M | 143.3M |
| Diluted Shares Outstanding | 143.1M | 141.5M | 132.7M | 143.3M | 143.3M |
| Profitability Metrics | |||||
| EBITDA | 401.7M | 497.3M | 574.9M | 350.0M | 531.7M |
| D&A | 164.5M | 155.7M | 146.3M | 140.8M | 138.2M |
| EBIT | 237.2M | 341.6M | 428.6M | 209.2M | 393.5M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026